D. Jones

Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1.

C. Charrier, M. Craighead, J. Maclean, 2020, RSC medicinal chemistry.

The discovery of orally available thrombin inhibitors: studies towards the optimisation of CGH1668.

D. Janus, K. Menear, David J. Farr, 1998, Bioorganic & medicinal chemistry letters.

Studies towards the identification of potent, selective and bioavailable thrombin inhibitors.

D. Janus, K. Menear, D. Bentley, 1999, Bioorganic & medicinal chemistry letters.

The identification and characterization of hydrazinyl urea-based antibacterial agents through combinatorial chemistry.

K L Morand, T. Morris, C. Parker, 2001, Bioorganic & medicinal chemistry letters.

Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transport.

P. Darke, E. Emini, R. Hirschmann, 1994, Journal of medicinal chemistry.

Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60G.

M. Grütter, J. Priestle, B. Wathey, 1999, Bioorganic & Medicinal Chemistry Letters.